Vesalius Longevity Labs (SPV) Inc. — Form D
Vesalius Longevity Labs (SPV) Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-27. The offering totals $895K, of which $895K was reported sold. Industry: Other.
Offering
- Filed: 2025-03-27
- Form: D
- Accession: 0002060755-25-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $895K
- Amount sold: $895K
- Investors: 6
- Date of first sale: 2025-03-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-542329
Issuer
- Name: Vesalius Longevity Labs (SPV) Inc.
- CIK: 0002056924
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2024
- Address: 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, A1, V6E 4N7
- Phone: 5076666151
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| SHANNON ANDERSON | Director | Vancouver, A1 |
| SHANNON ANDERSON | Promoter | Vancouver, A1 |
| CHRISTINA D PHALEN | Director | VANCOUVER, A1 |
| CHRISTINA D PHALEN | Executive Officer | VANCOUVER, A1 |
| SHANNON D ANDERSON | Director | VANCOUVER, A1 |
| Robert D McCue | Director | VANCOUVER, A1 |
| Robert D McCue | Executive Officer | VANCOUVER, A1 |
| Christina Phalen | Director | Vancouver, A1 |
| Christina Phalen | Executive Officer | Vancouver, A1 |
Other filings by this issuer (3)
More